SCHEMBL7621709

SCHEMBL7621709

BrCCCCCCCCCCCOC1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.45
NAAA Q02083 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11762708 0.98 NPC1 (0.42) NPC1NAAA
SCHEMBL4516905 0.98 NPC1 (0.47) NPC1NAAA
SCHEMBL4326261 0.96 NPC1 (0.43) NPC1NAAA
SCHEMBL20371021 0.92 NPC1 (0.42) NPC1NAAA
SCHEMBL4798852 0.89 SPHK1 (0.32) NPC1
SCHEMBL9011682 0.89 NPC1 (0.54) NPC1NAAA
SCHEMBL262805 0.89 NPC1 (0.54) NPC1NAAA
SCHEMBL9011791 0.89 NPC1 (0.54) NPC1NAAA
SCHEMBL9011906 0.89 NPC1 (0.54) NPC1NAAA
SCHEMBL9011558 0.86 NPC1 (0.56) NPC1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790824-B1 2,2-DICHLOROALKANE CARBOXYLIC ACIDS, PROCESS FOR PREPARING THE SAME, MEDICAMENT CONTAINING THE SAME, AND USE THEREOF FOR TREATING INSULIN RESISTANCE ROCHE DIAGNOSTICS GMBH (DE) 2002-02-06 EP disclosed
US-5968982-A TREATMENT OF DIABETES ROCHE DIAGNOSTICS GMBH (DE) 1999-10-19 US disclosed